4//SEC Filing
Bisker-Leib Vered 4
Accession 0001171843-24-000715
CIK 0001738021other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 12:50 PM ET
Size
5.9 KB
Accession
0001171843-24-000715
Insider Transaction Report
Form 4
Bisker-Leib Vered
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2024-02-08$1.45/sh−49,198$71,337→ 3,124,426 total
Footnotes (2)
- [F1]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs")
- [F2]300,000 of the shares represents unvested restricted stock units ("RSU") granted on November 16, 2021. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on November 16, 2022. 300,000 of the shares represents unvested restricted stock units ("RSU") granted on February 8, 2023. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on February 8, 2024. 1,753,125 of the shares represents unvested restricted stock units ("RSU") granted on January 9, 2024. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 9, 2025.
Documents
Issuer
Compass Therapeutics, Inc.
CIK 0001738021
Entity typeother
Related Parties
1- filerCIK 0001814093
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 12:50 PM ET
- Size
- 5.9 KB